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Abstract
Background: PRV Fa is common in China and causes most of the pseudorabies in the pig industry. A PRV SA215
strain with deleted gE, gI, and TK genes was constructed to develop a commercial attenuated live vaccine.
However, the physicochemical properties, growth pattern, penetration kinetics, and morphogenesis of the PRV
SA215 and its parental PRV Fa strain are unclear.
Results: A series of experiments were conducted to characterize both strains and provide more information. PRV
Fa and PRV SA215 were found to have similar penetration patterns, with about 5 min half-time of penetration. The
SA215 strain exhibited a slight delay in entry compared with PRV Fa. In the one-step growth test, the titers of the
SA215 strain were first detected at 8 h, rapidly increased, and peaked at 12 h. A plateau was formed between 12-
36 h of culturing. PRV SA215 showed delayed replication and approximately 10-30-fold lower titers during 0-16 h
of culturing compared with the PRV-Fa strain. After 16 h, the PRV Fa titers dramatically decreased, whereas those of
PRV SA215 were prolonged to 36 h and reached a titer value equal to that of PRV Fa and then decreased. Both
strains were sensitive to both heat and acid-alkali treatments; however, PRV Fa was relatively more stable to heat
treatment than PRV SA215. Both strains could propagate in the cultures with pH values from 5.0 to 9.0. Cultures
with pH below 3.0 or above 11.0 were fatal to both strains. Both strains had considerable resistance to freeze-
thawing treatments. Morphogenetic investigations showed that typical phases in the maturation pathway were
observed in the PRV Fa-infected PK15 cells, whereas secondary envelopment was not observed in the PRV SA215
strain. Instead, capsid aggregations with concomitants of electrodense materials were observed.
Conclusions: These results suggest that PRV SA215 is a promising strain for vaccine development
Keywords: pseudorabies virus, gene-deleted mutant strain, growth and physicochemical properties,
morphogenesis
Background
The pseudorabies virus (PRV) is a member of the
Alphaherpesvirinae subfamily in the family Herpesviri-
dae. It is the causative agent of Aujeszky’s disease [1].
The disease caused by PRV was first observed in cattle
and described as “mad itch” [2]. Swine is the primary
host and reservoir of this virus. PRV is able to infect
most mammals and some avian species. In young pig-
lets, as well as in the other susceptible species, PRV
infection is often fatal, and animals die from central ner-
vous system disorders, whereas older infected pigs
usually primarily develop respiratory symptoms. Similar
to other alpha herpesviruses, PRV infection is a life-long
latent infection of the peripheral nervous system. These
latently infected pigs can serve as sources of renewed
infection when the latent virus genome spontaneously
reactivates and infectious viruses are produced. In preg-
nant sows, PRV infections may cause the death of
fetuses and/or abortion. Thus, PRV is a pathogen with
major agricultural effects and economic importance [3].
Pigs are commonly vaccinated with attenuated live
PRV vaccines [4] to control the disease. These vaccine
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strains are attenuated by inactivation of one or more
genes that encode nonessential proteins. Studies found
that glycoprotein gE is dispensable for viral growth in
animals or in the cultures [5,6]; however, it is necessary
for virulence and virion replication [7,8], and plays an
important role in virion spread from cell to cell. A virus
with only a deletion of the gE gene is capable of repli-
cating in vivo and in vitro with considerable virulence.
Thus, most of the commercialized attenuated live vac-
cines are constructed based on gE deletion combined
with one or more of other gene deletions such as TK
[9]. However, this kind of vaccine has an attenuated
virulence and restricted infectivity. Inactivation of viral
genes was reported to often result in reduced replication
capacity. The highly virulent strain NIA-3, the interme-
diately virulent strain 2.4N3A, and the non-virulent
strain Bartha were compared in a study of the patho-
genicity of different PRV strains. The results showed
that the degree of virulence is directly related to the
ability of these viruses to replicate in the nasal epithe-
lium [10]. Reduced replication lowers the viral antigen
supply and may impair the immunogenicity of the
vaccine.
A gene deficient strain SA215 (gE-/gI-/TK-) was con-
structed in our laboratory based on a Chinese PRV Fa
strain [11]. The PRV Fa strain is the earliest isolated
typical strain that caused the prevalence of pseudorabies
in China and caused large economic losses in the pig
industry. The biological and physicochemical properties
and morphogenesis of both strains are still unclear. Pre-
liminary studies have shown that the PRV SA215 strain
has biologically secure properties with high immuno-
genicity and long-term immunity, and could be devel-
oped as a commercial attenuated live vaccine. However,
its growth, physicochemical properties, and morphogen-
esis during multiplication have not been investigated. In
the current paper, the results of recent studies on the
physicochemical properties and growth pattern, penetra-
tion kinetics and morphogenesis are presented to
provide more information about the Chinese typical




The PRV SA215 strain was constructed by our center
(Animal Biotechnology Center of Sichuan Agricultural
University) based on the Chinese PRV Fa strain. PRV
SA215 carries gE, gI, and TK gene deletions. The
strongly virulent wild-type PRV Fa strain was obtained
from the Institute of China Veterinary Medicine Inspec-
tion. PK15 cells and Vero cells were purchased from
CCTCC. DMEM, trypsin, and fetal calf serum were pur-
chased from GIBCO Inc. Methylcellulose was obtained
from Sigma Inc. Vero cells were used in the vaccine
strain propagation, plaque formation test, isolation and
titration of the PRV virus in nasal discharges, and sera
neutralization assays.
PRV Passaging
Vero cells were cultured in DMEM at 37°C and 5%
CO2. The nutrient solution contained 10% fetal calf
serum and 100 U/ml of penicillin and streptomycin.
The growth liquids were poured out when a dense cell
monolayer was formed in the culture flasks. The cell
monolayers were washed twice with calcium- and mag-
nesium-free water. 1-2 drops trypsin were added into
each flask to trypsinize the cells. The cells were split 1:2
for subsequent cultures.
Plaque formation test
The test was carried out to measure virus titration fol-
lowing our regular laboratory protocol. Briefly, the Vero
cells were grown on 6-well plates until the appearance
of cell monolayers. The virus samples were diluted 10
times and the samples with appropriate viral titers were
selected for inoculation, and 0.1 ml of this sample was
added into each well. The subject culture samples in the
plates were gently shaken to mix the samples well and
allowed to adsorb for 1 h at 37°C. A solution of 1%
methylcellulose was added to the wells to cover the cul-
ture medium. After the tested samples were cultured for
3-5 days at 37°C in a CO2-controlled incubator, the
methylcellulose was aspirated and 1 ml of formalin crys-
tal purple staining solution was added to fix and stain
the samples for 20 min. The staining solution was
removed by washing with tap water. The plaques were
counted and the PFU were calculated based on the
volumes of the original samples.
Penetration kinetics
The penetration kinetics of both strains was assayed
using low-pH inactivation of the extracellular virus
based on the method described by Mettenleiter [12].
Briefly, PRV Fa and PRV SA215 were inoculated on the
PK15 monolayer cells. The input virus amount was ca.
200 PFU per well in a six-well tissue culture plate.
After adsorption for 1 h at 4°C, the inoculants were
removed and the cells were covered with nutrient solu-
tion at 37°C to facilitate virus penetration. A lower pH
solution (pH 3.0, 40 mM citric acid-10 mM KCl-135
mM NaCl) was added to the wells for 2 min to inacti-
vate the extracellular viruses after 0, 5, 10, 20, and 40
min of penetration. The lower pH-treated cell mono-
layers were washed twice and covered with methylcel-
lulose solution. After culturing for 2-3 days, the cells
were fixed and stained. The plaques were counted and
the penetration percentages were calculated by
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comparing with the number of plaques formed in the
PBS-treated control.
One-step growth analysis
One-step growth analysis was performed according to
the method described by Klupp et al. [13]. The PK15
monolayer cells were infected with PRV Fa and PRV
SA215 at 0.005 multiplicity of infection (MOI) in each
well of a six-well tissue culture plate. The viruses were
allowed to adsorb for 1 h at 4°C. The extra viruses were
removed and the infected cells were covered with nutri-
ent solution at 37°C. After 90 min of culture and pene-
tration, the extracellular virus was inactivated with a low
pH solution. The maintenance growth solution for the
cells was then switched. The cell supernates and their
mixtures were collected at 0, 4, 8, 12, 16, 20, 24, 28, 32,
36, 40, 44, and 48 h. The cells were frozen at -70°C and
lysed by rapidly thawing at 37°C. Virion amount in dif-
ferent portions was determined by the plaque formation
test.
Assays for the physicochemical properties of the virus
Conventional methods were applied in the investigation
of physicochemical properties, which included testing
PRV heat-resistance, sensitivity to pH, and stability to
freeze-thawing treatment. (1) Both the PRV Fa and PRV
SA215 strains were heat-treated to test their heat-resis-
tance. Flasks containing either PRV Fa or PRV SA215
were incubated at 56°C and the titers were measured
after incubation for 0, 15, 30, 45, or 60 min. (2) PRV
sensitivity to acids and alkali were also investigated by
adjusting the culture medium pH to 3.0, 4.0, 5.0, 6.0,
7.0, 8.0, 9.0, 10.0, and 11.0 with 0.1 M HCl/NaOH solu-
tions. All the cultures were incubated at 37°C for 1 h,
and the pH values were then adjusted back to 7.0. The
plaques were measured to determine the virus titers and
sensitivity to pH. The titers were evaluated by calculat-
ing the acid and alkali amounts added based on the ori-
ginal sample volumes. (3) In the freeze thaw treatment,
the PRV viruses were repeatedly frozen below 20°C and
thawed at 37°C 1 to 5 times to determine the effects of
freeze-thawing on PRV multiplication, as indicated by
titers. All samples were assayed for titers after the
freeze-thaw treatment.
EM of PRV
The procedure described by Granzow et al. (1997) [14],
modified for routine electron microscopy (EM) observa-
tion, was used. The PK15 cell monolayers were infected
with PRV Fa or PRV SA215 at a MOI of 10. Both non-
infected and infected cell cultures in Petri dishes were
fixed at different times (12, 16, 20, and 24 h post-infec-
tion) after infection for 60 min with 2.5% glutaraldehyde
buffered in 0.1 M Na-cacodylate (pH 7.2, 300 mOsmol.
They were then scraped off the plate and pelleted by
low-speed centrifugation and embedded in LMP agarose
(GIBCO Inc). Small pieces were postfixed in 1.0% aqu-
eous OsO4 (company, city, country) and stained with
uranyl acetate. After stepwise dehydration in ethanol,
the cells were cleared in propylene oxide, embedded in
agarose, and polymerized at 59.8°C for 4 days. Ultrathin
sections, counterstained with uranyl acetate and lead
salts, were examined for morphogenesis using a trans-
mission electron microscope (H600 Japan).
Results
Penetration kinetics
The entry kinetics of PRV Fa and PRV SA215 were
determined using low-pH inactivation of the remaining
extracellular viruses to analyze viral penetration. As
shown in Figure 1, PRV Fa and PRV SA215 showed
similar penetration patterns and about 5 min half-time
penetration, although SA215 exhibited a slight delay in
entry compared with PRV Fa. These results indicate that
both strains have similar penetration ability, and the
penetration was not arrested in the constructed strain
PRV SA215.
PRV one-step growth kinetics
Vero cells were infected with the wild-type PRV Fa and
the constructed PRV SA215 strain at 5 MOI to assay
the replicative abilities of the two viruses. The cells,
supernates, and their mixtures were collected for titer
investigation. At various time points, the virus titers of
Figure 1 Penetration kinetics of PRV Fa and PRV SA215. The
penetration kinetics of PRV Fa and PRV SA215 into Vero cells was
analyzed by low-pH inactivation. Indicated is the percentage of PFU
that was resistant against treatment with pH 3.0 citrate buffer
compared with the control treated with phosphate-buffered saline
at different times after the temperature shift. Averages from three
independent experiments are indicated.
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the Vero cells were determined. The results are shown
in Figures 2 and 3. In the current study, the titers in the
SA215 strain cultures were determined at 8 h. After 8 h,
the virion titers rapidly increased and maintained a high
plateau during the 12-36 h culture period. The corre-
sponding pathologic changes were cell aggregation,
fusion, and formation of plaques at approximately 80%
CPE. PRV SA215 replicated with a delay and approxi-
mately 10-30-fold lower titers during the 0-16 h culture
compared with the PRV-Fa strain. After 16 h, the PRV
Fa titers dramatically decreased, whereas those of PRV
SA215 slowly crept to 36 h and reached a titer value
similar to PRV Fa, before rapidly decreasing. In addition,
PRV Fa was observed to cause cell desquamation and
crashing in a relative short time (28 h).
Physicochemical properties of the virus
The physicochemical properties of the wild-type PRV Fa
and the constructed PRV SA215 were compared in the
current study. The results from the heat-resistance test,
pH sensitivity, and stability to freeze-thawing treatment
are shown in Figures 4, 5 and 6.
The heat treatment of PRV SA215 and the wild-type
PRV Fa virus at 65°C at varying durations resulted in a
significant reduction in the titers in both strains, with
approximately 2 titers reduced in each 15 min slice dur-
ing the heat treatment (Figure 4). From heat treatment
time 0 to 60 min, the titers for both strains decreased
from approximately 9 to 3 lgPFU/ml; however, the PRV
Fa strain showed relatively higher titers at different time
points compared with PRV SA215 during the heat-resis-
tance test.
In different acid-alkali environments, both strains
showed similar sensitivity patterns (Figure 5). Both PRV
SA215 and PRV Fa were relatively stable in the cultures
with pH values of 5.0 to 9.0, and showed high titers of
around 7 lgPFU/ml. The virion titers rapidly decreased
when the culture pH was changed to less than 5.0 or
higher than 9.0. No detectable titers were observed and
all viruses were inactivated when the culture medium
pH was adjusted to 3.0 or 11.0.
The effect of repeated freeze-thawing on the titer
measurements of the two virus strains are shown in
Figure 2 One-step growth kinetics of PRV SA215. Vero cells
were infected with PRV SA215 at 5 MOI. Cells, supernates, and cell-
supernate mixtures were harvested at the indicated time points and
titrated on Vero cells. Averages and standard deviations from three
independent experiments are shown.
Figure 3 One-step growth kinetics of PRV SA215 and Fa. Vero
cells were infected with PRV SA215 at 5 MOI. Cells were harvested
at the indicated time points and titrated on Vero cells. Averages
and standard deviations from three independent experiments are
shown.
Figure 4 Titers determined at different time points of heat
treatment. Both strains were cultured under 65°C for 0, 15, 30, 45,
or 60 min and titers were determined at each time point. Averages
and standard deviations from three independent experiments are
shown.
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Figure 6. The freeze-thawing treatment decreased the
titer values. From 1 to 5 cycles of freeze-thawing treat-
ment, the titers of PRV Fa and PRV SA215 decreased
from 8.5 to 6.0 lgPFU/ml and 8.0 to 5.0 lgPFU/ml,
respectively.
Morphogenesis of PRV SA215
The morphogenesis of both the PRV SA215 strain and
its parental strain PRV Fa on PK15 cells were investi-
gated and compared under an electron microscope to
test the effects of the PRV SA215 strain on the replica-
tion in infected cells.
A number of virions were found after the PK15 cells
were infected with the PRV Fa strain. A typical herpes-
virus nucleocapsid morphogenesis pathway in intranuc-
lear maturation was identifiable, including nucleocapsid
assembly (Figure 7A), formation of a secondary envelope
from transportation via the inner nuclear membrane
(Figures 7B and 7C), loss of the primary envelope and
release of the nucleocapsid into the cytoplasm in the
outer nuclear membrane (Figure 7D), formation of
encapsulated vesicles and envelopes in the trans-Golgi
area (Figures 7E and 7F), and the release of mature
virions into the cytoplasm via transport vesicles
(Figure 7F).
In the current study, virion adsorption, nucleocapsid
formation, and DNA encapsulation were not influenced
by gene deletions (Figures 8A, B and 8C) in the PRV
SA215 strain. Nucleocapsids acquired primary envelopes
by budding through the inner nuclear membrane, and
were released into the cytoplasm through nuclear mem-
brane fusion and loss of the primary envelope (Figures
8D and 8E). Nucleocapsids obtaining secondary envel-
opes by budding into the vesicles in the trans-Golgi area
(Figure 8F) and the mature virions being released out-
side the vesicle via transport vesicles through exocytosis
were observed (Figure 8G). Some abnormal morphologic
changes were also observed, such as the inclusion bodies
of non-envelope capsids with concomitants of electro-
dense materials derived from the coating membrane
proteins (Figure 8H), and arrest in the budding through
the inner nuclear membrane, resulting in a mass of
nucleocapsids in the inner or inside the nuclear mem-
brane (Figure 8I). Amazingly, a large number of vesicles
from the nucleocapsids in the nucleus were also
observed (Figure 8J). These results indicate that the for-
mation of secondary envelopes and virion exocytosis
could be observed under EM after the PK15 cells were
infected with PRV SA215. However, electrodense cyto-
plasmic materials were found, as well as capsids, which
demonstrate that budding in the nuclear membrane and
envelope formation were impaired or delayed to some
extent.
Discussion
The initiation of PRV adsorption in target cells is
reportedly associated with the interaction of gC and
acetyl heparin, with the secondary adsorption mediated
by gD [15]. The adsorption is followed by fusion of the
viral envelope with the cytoplasmic membrane. Glyco-
proteins gB, gD, gH, and possibly gL, are associated
with and essential for the fusion process [16]. The
results of the current study indicate that the adsorption
and penetration of the gE-/gI-/TK-PRV SA215 strain
were not impaired, which infers that gE, gI, and TK
were not essential for PRV adsorption and penetration.
Figure 5 Titers in cultures with varied pH. The viruses were
cultured at varying medium pH. The titers were assayed. Averages
and standard deviations from three independent experiments are
shown.
Figure 6 PRV titers influenced by freeze-thawing treatments.
The PRV virus was treated with different freeze-thawing durations
and cultured at 37°C for 1 h. Titers were determined in each
treatment. Averages plotted and standard deviations from three
independent experiments are shown.
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PRV SA215 showed a postponed appearance of detect-
able titers and slowed growth compared with the paren-
tal strain PRV Fa. However, equal titers in the SA215
strain and in its parental strain Fa were observed. SA215
was also found capable of maintaining high titers for a
much longer time than PRV Fa. These results are in
agreement with the expected results of the functional
deficiency of the gE, gI, and TK genes. PRV uses two
methods to spread virions in the infection: a direct cell
to cell spreading, and releasing virions for adsorption by
uninfected cells. The first method is mediated by the
glycoprotein gE, whereas the latter requires glycoprotein
gC involvement. Although the gE gene-deleted mutant
strain lacks the capability to directly spread virions from
cell to cell, this strain can use the second mechanism to
be adsorbed by uninfected host cells and then infect and
proliferate in the cells to produce titers equal to that of
the wild-type PRV [17]. In PRV infection, gI exerts its
functions by forming a complex with gE. Mutant strains
with either gI, gE, or both genes deleted were reported
Figure 7 Morphogenesis of the wild-type PRV Fa strain. Formation of capsids in the PK15 cell nucleus and a large number of nucleocapsids
aggregated and arrayed as pseudocrystals were observed under 25,000 × amplification (A). The gap in the nuclear membrane was distended
and a nucleocapsid was budding through the inner nuclear membrane to acquire a primary envelope indicated by the arrow (B, 30,000×).
Virions in the envelope and numerous nucleocapsids scattered in the nucleus were observed (C, 25,000×). Fusion of a primary envelope with the
outer nuclear membrane, and nucleocapsids released into the cytoplasm, and loss of a primary envelope; the arrow points to a budding process
(D, 20,000×). A secondary envelope was acquired in the trans-Golgi area of the perinuclear cisterna (E, 25,000×). Newly produced viral progeny
was released to the cell surface through the fusion of a transport vesicle and the cytoplasmic membrane via exocytosis (F, 30,000×).
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Figure 8 Morphogenesis of the constructed PRV SA215 strain (A to J). Virion adsorption and penetration (A, 35,000×) and formation and
release of nucleocapsids into the cytoplasm (B, 30,000×) were observed. A large number of nucleocapsids aggregated and arrayed as
pseudocrystals in the cell nucleus with insignificant enlargement of the nuclear membrane, and virion budding into the nuclear membrane were
seen (C, 20,000×). Nucleocapsids budding through the inner membrane to obtain a primary envelope and budding out from the outer nuclear
membrane to gain a secondary envelope, and loss of a primary envelope in the endoplasmic reticulum (D, 20,000×). Nucleocapsid release
through the nuclear membrane and virions wrapped with tubular vesicles (E, 30,000×). Cytoplasmic nucleocapsids gaining envelopes through
budding into the vesicles (F, 30,000×). Virion release (G, 30,000×). A large number of non-envelope capsids aggregated with electron-dense
concomitant materials were found in the cytoplasm (H, 20,000×). Numerous nucleocapsids amassed in the inner or inside the nuclear membrane
(I, 25,000×). Several envelopes from the nucleocapsids were observed in the nucleus (J, 15,000×)
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to have similar biological properties [18]. All these
results demonstrate that SA215 can easily grow and pro-
liferate in cells, and can be used as a commercial vac-
cine strain.
In the current study, the physicochemical properties of
PRV SA215 and its parental strain PRV Fa were investi-
gated. The results showed that both strains have compar-
able features. Both strains were sensitive to heat
inactivation. Prolonged heating at 65°C could kill all of
the viruses. These strains were also sensitive to culture
pH. Although they demonstrated relative stability to pH
and retained high viral titers in the culture medium with
pH values ranging from 5.0 to 9.0, their replications were
inhibited when the culture medium pH were beyond 5.0
and 9.0. Furthermore, pH 3.0 and 11.0 were fatal to both
strains. PRV Fa and PRV SA215 were relatively stable
under the freeze-thaw treatment and showed consider-
able resistance to repeated freezing and thawing treat-
ments. Interestingly, extending the vaccine shelf life and
storage time based on these results is possible if the
SA215 strain was used for vaccine production.
Generally, PRV virions are assembled stepwise in the
host cell. Newly replicated DNA is encapsidated into
nucleocapsids in the cell nucleus. These nucleocapsids
are then translocated into the cytoplasm by envelop-
ment and de-envelopment. In the cytoplasm, a second-
ary envelope is acquired by the budding of the
nucleocapsids into the trans-Golgi vesicles, which are
then transported to the cell surface [19]. In the current
study, similar results were observed in PRV Fa-infected
cells. All the typical maturation phases in morphogen-
esis were observed in the ultrathin sections of PRV Fa-
infected pK15 cells under EM. Compared with the wild-
type PRV Fa strain, virion adsorption, penetration, for-
mation of capsids and DNA capsulization in nucleus,
primary envelope formation by budding through the
inner nuclear membrane and de-envelopment by fusion
with the outer nuclear membrane, nucleocapsid release
to the cytoplasm, secondary envelopment through
nucleocapsid budding into the vesicles in the trans-
Golgi area, and the release of mature virions to the cell
surface during PRV SA215 morphogenesis were
observed. In addition, some atypical morphologic
changes in some parts of the infected cells were also
observed. Numerous nucleocapsids amassed in the inner
side and in the inside of the nuclear membranes, and
the release of nucleocapsids was impaired. Normal pri-
mary envelopment during budding through the inner
membrane was not observed. Interestingly, the amassed
non-enveloped capsids with concomitants of electro-
dense materials from the coating membrane proteins in
the cytoplasm were also observed. Brack et al. [20,21]
reported numerous electrodense materials in the cyto-
plasm of cells infected with gE- and gI-deleted PRV
strains; however, these authors did not observe capsids.
In their studies, PRV morphogenesis was not affected by
double gene deletions, and secondary envelopment and
exocytosed virions were observed. The authors con-
cluded that this phenotypic change was attributed to the
loss of the interaction between the cytoplasmic tail of
gE and the special capsid components.
Conclusions
In the current study, the physicochemical properties of
PRV SA215 and its parental strain PRV Fa were investi-
gated. All these results suggest that PRV SA215 is a pro-
mising strain for vaccine development.
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